Cargando…
The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK
BACKGROUND: Despite intensive study of high-risk mucosal human papillomaviruses (HPV), little is known of the epidemiology of cutaneous HPV. As part of a study of cutaneous squamous cell carcinoma and HPV among organ transplant recipients (OTR) from London and Oxford, we investigated the seroprevale...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749815/ https://www.ncbi.nlm.nih.gov/pubmed/19751499 http://dx.doi.org/10.1186/1750-9378-4-13 |
_version_ | 1782172185910050816 |
---|---|
author | Casabonne, Delphine Waterboer, Tim Michael, Kristina M Pawlita, Michael Lally, Aoife Mitchell, Liza Imko-Walczuk, Beata Wojnarowska, Fenella Newton, Robert Proby, Charlotte Harwood, Catherine |
author_facet | Casabonne, Delphine Waterboer, Tim Michael, Kristina M Pawlita, Michael Lally, Aoife Mitchell, Liza Imko-Walczuk, Beata Wojnarowska, Fenella Newton, Robert Proby, Charlotte Harwood, Catherine |
author_sort | Casabonne, Delphine |
collection | PubMed |
description | BACKGROUND: Despite intensive study of high-risk mucosal human papillomaviruses (HPV), little is known of the epidemiology of cutaneous HPV. As part of a study of cutaneous squamous cell carcinoma and HPV among organ transplant recipients (OTR) from London and Oxford, we investigated the seroprevalence and risk factors for 34 HPV types (detected using Luminex technology) among 425 Caucasian OTR without skin cancer. RESULTS: Overall, 86% of participants were seropositive to at least one HPV: 41% to mucosal alpha types, 33% to cutaneous alpha types, 57% to alpha types, 56% to beta, 47% to gamma types and 45% to other types (nu, mu, HPV101 and 103). In both centres, the most common types were HPV6 (33% and 26% for London and Oxford respectively), HPV8 (24% and 18%), HPV15 (26% and 29%), HPV17 (25% and 21%), HPV38 (23% and 21%), HPV49 (19% and 21%), HPV4 (27% and 23%), HPV65 (30% and 25%), HPV95 (22% and 20%), HPV1 (33% and 24%) and HPV63 (28% and 17%). The seroprevalence of 8 HPV types differed significantly (P < 0.05) between London and Oxford. Those individuals seropositive to multiple types of one genus were more likely to be seroreactive to multiple types of another genus. As expected, antibodies against mucosal alphaHPV types were more frequent in younger patients and among women. Sunbed use and sunbathing was associated with seropositivity to multiple gammaHPV (P-trend = 0.007) and self-history of abnormal smear was related to seroactivity to multiple betaHPV (P = 0.01). Skin type and other self reported markers of exposure to ultraviolet radiation were not consistently associated with any HPV types. No other distinguishing epidemiological features of transplant recipients with antibodies against single or multiple HPV types were identified. CONCLUSION: Findings for mucosal HPV types were in line with results from previous studies. We observed differences in HPV seroprevalence between organ transplant recipients from two geographically close centres but no clear risk factor was found associated with cutaneous HPV seropositivity among organ transplant recipients. These findings have implications for interpretation of future seroepidemiology studies addressing the association between HPV and cutaneous SCC in OTR populations. |
format | Text |
id | pubmed-2749815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27498152009-09-24 The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK Casabonne, Delphine Waterboer, Tim Michael, Kristina M Pawlita, Michael Lally, Aoife Mitchell, Liza Imko-Walczuk, Beata Wojnarowska, Fenella Newton, Robert Proby, Charlotte Harwood, Catherine Infect Agent Cancer Research Article BACKGROUND: Despite intensive study of high-risk mucosal human papillomaviruses (HPV), little is known of the epidemiology of cutaneous HPV. As part of a study of cutaneous squamous cell carcinoma and HPV among organ transplant recipients (OTR) from London and Oxford, we investigated the seroprevalence and risk factors for 34 HPV types (detected using Luminex technology) among 425 Caucasian OTR without skin cancer. RESULTS: Overall, 86% of participants were seropositive to at least one HPV: 41% to mucosal alpha types, 33% to cutaneous alpha types, 57% to alpha types, 56% to beta, 47% to gamma types and 45% to other types (nu, mu, HPV101 and 103). In both centres, the most common types were HPV6 (33% and 26% for London and Oxford respectively), HPV8 (24% and 18%), HPV15 (26% and 29%), HPV17 (25% and 21%), HPV38 (23% and 21%), HPV49 (19% and 21%), HPV4 (27% and 23%), HPV65 (30% and 25%), HPV95 (22% and 20%), HPV1 (33% and 24%) and HPV63 (28% and 17%). The seroprevalence of 8 HPV types differed significantly (P < 0.05) between London and Oxford. Those individuals seropositive to multiple types of one genus were more likely to be seroreactive to multiple types of another genus. As expected, antibodies against mucosal alphaHPV types were more frequent in younger patients and among women. Sunbed use and sunbathing was associated with seropositivity to multiple gammaHPV (P-trend = 0.007) and self-history of abnormal smear was related to seroactivity to multiple betaHPV (P = 0.01). Skin type and other self reported markers of exposure to ultraviolet radiation were not consistently associated with any HPV types. No other distinguishing epidemiological features of transplant recipients with antibodies against single or multiple HPV types were identified. CONCLUSION: Findings for mucosal HPV types were in line with results from previous studies. We observed differences in HPV seroprevalence between organ transplant recipients from two geographically close centres but no clear risk factor was found associated with cutaneous HPV seropositivity among organ transplant recipients. These findings have implications for interpretation of future seroepidemiology studies addressing the association between HPV and cutaneous SCC in OTR populations. BioMed Central 2009-09-14 /pmc/articles/PMC2749815/ /pubmed/19751499 http://dx.doi.org/10.1186/1750-9378-4-13 Text en Copyright © 2009 Casabonne et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Casabonne, Delphine Waterboer, Tim Michael, Kristina M Pawlita, Michael Lally, Aoife Mitchell, Liza Imko-Walczuk, Beata Wojnarowska, Fenella Newton, Robert Proby, Charlotte Harwood, Catherine The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK |
title | The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK |
title_full | The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK |
title_fullStr | The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK |
title_full_unstemmed | The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK |
title_short | The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK |
title_sort | sero-epidemiology of human papillomavirus among caucasian transplant recipients in the uk |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749815/ https://www.ncbi.nlm.nih.gov/pubmed/19751499 http://dx.doi.org/10.1186/1750-9378-4-13 |
work_keys_str_mv | AT casabonnedelphine theseroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT waterboertim theseroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT michaelkristinam theseroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT pawlitamichael theseroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT lallyaoife theseroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT mitchellliza theseroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT imkowalczukbeata theseroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT wojnarowskafenella theseroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT newtonrobert theseroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT probycharlotte theseroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT harwoodcatherine theseroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT casabonnedelphine seroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT waterboertim seroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT michaelkristinam seroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT pawlitamichael seroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT lallyaoife seroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT mitchellliza seroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT imkowalczukbeata seroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT wojnarowskafenella seroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT newtonrobert seroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT probycharlotte seroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk AT harwoodcatherine seroepidemiologyofhumanpapillomavirusamongcaucasiantransplantrecipientsintheuk |